Syneron Medical Ltd (ELOS) Tops Q1 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Syneron Medical Reports First Quarter 2016 Revenue of $68.7 Million
May 19, 2016 7:00 AM EDTIRVINE, Calif., May 19, 2016 /PRNewswire/ --Â Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, today announced financial results for the three month period ended March 31, 2016.
First Quarter 2016 Non-GAAP2 Highlights:
Revenue of $68.7 million, up 8.4% year-over-year Emerging products, which represent the Company's strategic growth drivers, grew 34%, primarily driven by the Body Shaping portfolio Total product revenue grew 9.5% year-over-year Non-GAAP net income of $1.3 million, or $0.04 per share, compared to... More